06:04 EDT Tonix Pharmaceuticals (TNXP) files $500M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNXP:
- Tonix Pharma Signs Major Sales Agreements for Funding
- Tonix Pharmaceuticals price target raised to $65 from $11 at Alliance Global Partners
- Tonix Pharma Begins Phase 2 OASIS Trial
- Tonix Pharmaceuticals announces first patient dosed in Phase 2 OASIS study
- Tonix, Illumina, HP, Schwab & Carvana: Insider Moves!